Unlock stock picks and a broker-level newsfeed that powers Wall Street.
15 Merger Arbitrage Opportunities in 2023

In This Article:

In this article we present the list of 15 merger arbitrage opportunities in 2023. Click to skip ahead and see the 5 Merger Arbitrage Opportunities in 2023.

Merger Arbitrage is a popular investment strategy that strives to take advantage of uncertainties between when a merger or acquisition is announced and when it's completed. When executed properly, it can guarantee annualized gains of between 3% and 5% or more. With Lina Khan at the helm of the Federal Trade Commission (FTC), behemoths are struggling to close M&A deals presenting unique arbitrage opportunities. The agency moving to block Amgen's $27.8 billion takeover of Horizon affirms how the agency is going against the most powerful businesses resulting in the widening of arbitrage spreads that hedge funds and investors are taking advantage of.

The merger arbitrage strategy entails buying and selling stocks of two merging companies to create risk-free profit. It mostly takes two forms. Pure Arbitrage entails buying the target company with the expectation that its share price will increase when the acquisition news hits the market.

If an investor already owns shares prior to the announcement, they can benefit from the share price increasing on the acquirer tabling a premium price for the shares. The difference between the price the acquirer is buying the target company and the prevailing market price is the arbitrage spread. The wider the spread, the greater the prospects of earning with the merger arbitrage strategy.

On the other hand, speculative arbitrage entails buying the target company in an M&A deal in anticipation that its share price will go up once the deal closes. If the deal falls through for several reasons, the share price often drops, resulting in losses for people who bought the stocks after the announcement.

The merger arbitrage strategy is not risk-free and comes with its fair share of risks. The uncertainty of whether the merger will be completed is one of the biggest risks exacerbated with MS Khan at the FTC in recent years.

For the longest time, MS Khan had insisted that the FTC was simply backing and not biting as behemoths turned to mergers and acquisitions to grow their monopolistic powers. Two years into her tenure at the FTC, Wall Street is increasingly learning how far she is willing to take the fight against America's powerful businesses.

Merger arbitrage investors had their worst month of the year in May as Khan ramped up the FTC push to block deals over antitrust concerns. The agency has already sought to block Amgen's takeover of Horizon Therapeutics.